Cargando…

Reduction in Standard Cancer Screening in 2020 throughout the U.S.

SIMPLE SUMMARY: The COVID-19 pandemic has had a significant impact on health care including cancer screening. We examined 2020 compared to the 2014–2019 cancer screening percentages in the United States (US) based on a national survey. We saw overall decreases in screening mammograms, pap tests, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Dennis, Leslie K., Hsu, Chiu-Hsieh, Arrington, Amanda K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656505/
https://www.ncbi.nlm.nih.gov/pubmed/34885028
http://dx.doi.org/10.3390/cancers13235918
_version_ 1784612297195388928
author Dennis, Leslie K.
Hsu, Chiu-Hsieh
Arrington, Amanda K.
author_facet Dennis, Leslie K.
Hsu, Chiu-Hsieh
Arrington, Amanda K.
author_sort Dennis, Leslie K.
collection PubMed
description SIMPLE SUMMARY: The COVID-19 pandemic has had a significant impact on health care including cancer screening. We examined 2020 compared to the 2014–2019 cancer screening percentages in the United States (US) based on a national survey. We saw overall decreases in screening mammograms, pap tests, and sigmoidoscopy/colonoscopy. Most decreases were higher among American Indian/Alaskan Natives, Hispanics, and multiracial participants, but decreases in pap test were also high among African-Americans/Blacks. As the pandemic expanded into 2021, cancer screening reduction is expected to be higher, increasing cancer disparities. ABSTRACT: Cancer screening is an important way to reduce the burden of cancer. The COVID-19 pandemic created delays in screening with the potential to increase cancer disparities in the United States (U.S.). Data from the 2014–2020 Behavioral Risk Factor Surveillance System (BRFSS) survey were analyzed to estimate the percentages of adults who reported cancer screening in the last 12 months consistent with the U.S. Preventive Services Task Force (USPSTF) recommendation for cervical (ages 21–65), breast (ages 50–74), and colorectal cancer (ages 50–75) prior to the pandemic. Cancer screening percentages for 2020 (April–December excluding January–March) were compared to screening percentages for 2014–2019 to begin to look at the impact of the COVID-19 pandemic. Screening percentages for 2020 were decreased from those for 2014–2019 including several underserved racial groups. Decreases in mammography and colonoscopy or sigmoidoscopy were higher among American Indian/Alaskan Natives, Hispanics, and multiracial participants, but decreases in pap test were also highest among Hispanics, Whites, Asians, and African-Americans/Blacks. Decreases in mammograms among women ages 40–49 were also seen. As the 2020 comparison is conservative, the 2021 decreases in cancer screening are expected to be much greater and are likely to increase cancer disparities substantially.
format Online
Article
Text
id pubmed-8656505
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86565052021-12-10 Reduction in Standard Cancer Screening in 2020 throughout the U.S. Dennis, Leslie K. Hsu, Chiu-Hsieh Arrington, Amanda K. Cancers (Basel) Article SIMPLE SUMMARY: The COVID-19 pandemic has had a significant impact on health care including cancer screening. We examined 2020 compared to the 2014–2019 cancer screening percentages in the United States (US) based on a national survey. We saw overall decreases in screening mammograms, pap tests, and sigmoidoscopy/colonoscopy. Most decreases were higher among American Indian/Alaskan Natives, Hispanics, and multiracial participants, but decreases in pap test were also high among African-Americans/Blacks. As the pandemic expanded into 2021, cancer screening reduction is expected to be higher, increasing cancer disparities. ABSTRACT: Cancer screening is an important way to reduce the burden of cancer. The COVID-19 pandemic created delays in screening with the potential to increase cancer disparities in the United States (U.S.). Data from the 2014–2020 Behavioral Risk Factor Surveillance System (BRFSS) survey were analyzed to estimate the percentages of adults who reported cancer screening in the last 12 months consistent with the U.S. Preventive Services Task Force (USPSTF) recommendation for cervical (ages 21–65), breast (ages 50–74), and colorectal cancer (ages 50–75) prior to the pandemic. Cancer screening percentages for 2020 (April–December excluding January–March) were compared to screening percentages for 2014–2019 to begin to look at the impact of the COVID-19 pandemic. Screening percentages for 2020 were decreased from those for 2014–2019 including several underserved racial groups. Decreases in mammography and colonoscopy or sigmoidoscopy were higher among American Indian/Alaskan Natives, Hispanics, and multiracial participants, but decreases in pap test were also highest among Hispanics, Whites, Asians, and African-Americans/Blacks. Decreases in mammograms among women ages 40–49 were also seen. As the 2020 comparison is conservative, the 2021 decreases in cancer screening are expected to be much greater and are likely to increase cancer disparities substantially. MDPI 2021-11-25 /pmc/articles/PMC8656505/ /pubmed/34885028 http://dx.doi.org/10.3390/cancers13235918 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Dennis, Leslie K.
Hsu, Chiu-Hsieh
Arrington, Amanda K.
Reduction in Standard Cancer Screening in 2020 throughout the U.S.
title Reduction in Standard Cancer Screening in 2020 throughout the U.S.
title_full Reduction in Standard Cancer Screening in 2020 throughout the U.S.
title_fullStr Reduction in Standard Cancer Screening in 2020 throughout the U.S.
title_full_unstemmed Reduction in Standard Cancer Screening in 2020 throughout the U.S.
title_short Reduction in Standard Cancer Screening in 2020 throughout the U.S.
title_sort reduction in standard cancer screening in 2020 throughout the u.s.
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656505/
https://www.ncbi.nlm.nih.gov/pubmed/34885028
http://dx.doi.org/10.3390/cancers13235918
work_keys_str_mv AT dennislesliek reductioninstandardcancerscreeningin2020throughouttheus
AT hsuchiuhsieh reductioninstandardcancerscreeningin2020throughouttheus
AT arringtonamandak reductioninstandardcancerscreeningin2020throughouttheus